Featured
-
-
Article
| Open AccessIntra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study
- Simon Pernot
- , Olivier Pellerin
- & Julien Taieb
-
Editorial |
Producing the appropriate model and drug for intratumoural ablation
- Christoforos Kosmidis
- , Chrysanthi Sardeli
- & Konstantinos Sapalidis
-
Translational Therapeutics
| Open AccessSigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer
- C Zeng
- , S Vangveravong
- & R H Mach
-
Translational Therapeutics
| Open AccessSurface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery
- J PosthumaDeBoer
- , S R Piersma
- & M N Helder
-
Clinical Study
| Open AccessSubcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
- O Shpilberg
- & C Jackisch
-
Clinical Study
| Open AccessA multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
- A H Ko
- , M A Tempero
- & L-T Chen